Quick Heal Technologies Ltd is Rated Strong Sell

Mar 22 2026 10:10 AM IST
share
Share Via
Quick Heal Technologies Ltd is rated Strong Sell by MarketsMojo. This rating was last updated on 02 Dec 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 23 March 2026, providing investors with the latest insights into its performance and outlook.
Quick Heal Technologies Ltd is Rated Strong Sell

Current Rating Overview

MarketsMOJO's Strong Sell rating for Quick Heal Technologies Ltd signals a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market and its sector peers. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. The Mojo Score currently stands at 26.0, down from 31.0 at the previous rating update, underscoring increased concerns about the company's prospects.

Quality Assessment

As of 23 March 2026, Quick Heal Technologies exhibits an average quality grade. The company’s long-term growth trajectory has been disappointing, with net sales declining at an annualised rate of -1.02% over the past five years. Operating profit has deteriorated even more sharply, registering a negative growth rate of -178.20% during the same period. These figures indicate challenges in sustaining profitable operations and suggest structural issues within the business model or competitive pressures in the software products sector.

Valuation Perspective

The valuation grade is classified as risky. Currently, the stock trades at levels that are unfavourable compared to its historical averages, reflecting investor scepticism. Negative EBITDA further compounds valuation concerns, signalling that the company is not generating sufficient earnings before interest, taxes, depreciation, and amortisation to cover its operational costs. This elevated risk profile is mirrored in the stock’s recent price performance, which has seen a steep decline.

Financial Trend Analysis

The financial grade is flat, indicating stagnation rather than improvement or deterioration in recent quarters. The latest half-year data reveals some worrying signs: the debtors turnover ratio is at a low 1.57 times, suggesting slower collection cycles and potential liquidity constraints. Cash and cash equivalents stand at a modest ₹6.84 crores, limiting the company’s buffer against operational disruptions. Additionally, non-operating income accounts for 155.65% of profit before tax, highlighting reliance on non-core activities rather than sustainable business earnings.

Technical Outlook

Technically, the stock is rated bearish. Price trends over various time frames confirm this negative momentum. As of 23 March 2026, Quick Heal Technologies has delivered a 1-year return of -53.24%, significantly underperforming the BSE500 index and reflecting weak investor sentiment. The stock’s 3-month and 6-month returns are also deeply negative at -47.11% and -57.25%, respectively. These trends suggest continued downward pressure and limited near-term recovery prospects.

Performance Summary and Investor Implications

The combination of average quality, risky valuation, flat financial trends, and bearish technicals culminates in the Strong Sell rating. Investors should be aware that the stock has underperformed both in the short and long term, with negative returns across all key periods. The company’s operational challenges, coupled with liquidity concerns and unfavourable market positioning, warrant a cautious approach. For risk-averse investors, this rating advises avoiding new exposure or considering exit strategies to mitigate potential losses.

Key Financial and Market Metrics as of 23 March 2026

Quick Heal Technologies Ltd is classified as a smallcap within the Software Products sector. The stock’s recent price movements include a marginal 1-day gain of +0.07%, but this is overshadowed by significant declines over longer periods: -1.03% over one week, -19.62% over one month, and a steep -57.25% over six months. Year-to-date performance stands at -45.95%, reinforcing the negative trend. Profitability has also suffered, with profits falling by -74.2% over the past year, further validating the cautious stance.

Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!

  • - Current monthly selection
  • - Single best opportunity
  • - Elite universe pick

Get the Full Details →

Contextualising the Rating Within the Sector

Within the Software Products sector, Quick Heal Technologies’ performance is notably weaker than many peers who have demonstrated resilience and growth amid evolving technology demands. The company’s inability to generate positive EBITDA and its reliance on non-operating income contrast with sector leaders who maintain robust operational cash flows and expanding market share. This divergence highlights the importance of fundamental strength and operational efficiency in sustaining investor confidence.

What the Strong Sell Rating Means for Investors

A Strong Sell rating from MarketsMOJO is a clear signal for investors to exercise caution. It suggests that the stock is expected to continue underperforming and may carry elevated risks of capital erosion. For existing shareholders, this rating encourages a thorough review of portfolio exposure and consideration of risk mitigation strategies. Prospective investors are advised to seek alternative opportunities with stronger fundamentals and more favourable valuations.

Conclusion

Quick Heal Technologies Ltd’s current Strong Sell rating reflects a comprehensive assessment of its operational challenges, valuation risks, stagnant financial trends, and negative technical signals. As of 23 March 2026, the stock’s performance metrics and financial health do not support a positive outlook. Investors should carefully weigh these factors when making decisions and consider the broader market context and sector dynamics before committing capital.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News